Danish pharmaceutical firms to be repaid millions of dollars due to typo
The Danish Medicines Agency did not have to authority to require special payments from Danish pharmaceutical firms, and will have to pay back large amounts Novo Nordisk, Lundbeck, and more.
by mads oddershede, translated by daniel pedersen
The Danish Medicines Agency did not have the authority to require additional fees from pharmaceutical firms with over 500 employees in Denmark after some caveats were removed from from documents, the authority confirms to Danish broadcast TV2.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
.jpg)
